RXi Pharmaceuticals Analysis
RXi Pharmaceuticals is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of RXi Pharmaceuticals delisted stock analysis is to determine its intrinsic value, which is an estimate of what RXi Pharmaceuticals is worth, separate from its market price. There are two main types of RXi Pharmaceuticals' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect RXi Pharmaceuticals' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of RXi Pharmaceuticals' stock to identify patterns and trends that may indicate its future price movements.
The RXi Pharmaceuticals stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. RXi Pharmaceuticals is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. RXi Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and RXi Pharmaceuticals' ongoing operational relationships across important fundamental and technical indicators.
RXi |
RXi Stock Analysis Notes
The company has price-to-book ratio of 0.84. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. RXi Pharmaceuticals recorded a loss per share of 2.29. The entity had not issued any dividends in recent years. The firm had 1:30 split on the 8th of January 2018. RXi Pharmaceuticals Corporation, a biotechnology company, focuses on discovering and developing immuno-oncology therapeutics to treat cancer. The company was incorporated in 2011 and is headquartered in Marlborough, Massachusetts. RXi Pharmaceuticals operates under Biotechnology classification in USA and is traded on Nasdaq Capital Markets. It employs 15 people. To find out more about RXi Pharmaceuticals contact Geert Cauwenbergh at 508-767-3861 or learn more at http://www.rxipharma.com.RXi Pharmaceuticals Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. RXi Pharmaceuticals' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding RXi Pharmaceuticals or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| RXi Pharmaceuticals is not yet fully synchronised with the market data | |
| RXi Pharmaceuticals has some characteristics of a very speculative penny stock | |
| RXi Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 153 K. Net Loss for the year was (7.63 M) with loss before overhead, payroll, taxes, and interest of (5.36 M). | |
| RXi Pharmaceuticals currently holds about 3.24 M in cash with (7.97 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.73. |
RXi Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 6 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate RXi Pharmaceuticals's market, we take the total number of its shares issued and multiply it by RXi Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding RXi Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Share Portfolio Now
Share PortfolioTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in RXi Stock
If you are still planning to invest in RXi Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RXi Pharmaceuticals' history and understand the potential risks before investing.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |